Targeting Engineered Nanoparticles for Breast Cancer Therapy
Breast cancer (BC) is the second most common cancer in women globally after lung cancer. Presently, the most important approach for BC treatment consists of surgery, followed by radiotherapy and chemotherapy. The latter therapeutic methods are often unsuccessful in the treatment of BC because of the...
Guardado en:
Autores principales: | Kumar Ganesan, Yan Wang, Fei Gao, Qingqing Liu, Chen Zhang, Peng Li, Jinming Zhang, Jianping Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/956046552f0446d194d44db625b95a11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanoparticles for Ferroptosis Therapy in Cancer
por: Nadia Zaffaroni, et al.
Publicado: (2021) -
Cost-effectiveness analysis of antiemetics therapy in breast cancer patients with moderate emetogenic chemotherapy in Prof. Dr. Margono Soekarjo Hospital, Indonesia
por: Ida Dzikriyani,, et al.
Publicado: (2021) -
A Nanoparticle Delivery of Plasmid Encoding Hepatocyte Growth Factor for Gene Therapy of Silicosis in Mice
por: Haiying Duan, et al.
Publicado: (2021) -
Medical Applications of Metallic Bismuth Nanoparticles
por: Catherine Gomez, et al.
Publicado: (2021) -
Particle Engineering of Chitosan and Kaolin Composite as a Novel Tablet Excipient by Nanoparticles Formation and Co-Processing
por: Chonwipa Yarangsee, et al.
Publicado: (2021)